GSK sees strong growth as Haleon split and vaccine drive pays off
GSK beat market estimates for fourth-quarter results on Wednesday (Jan 31), and unveiled an upbeat forecast for 2024 and beyond on the...
GSK to buy Asthma drug developer Aiolos for up to US$1.4 billion
GSK agreed to buy Aiolos Bio, spending as much as US$1.4 billion to gain a promising respiratory medicine.
GSK’s cancer drug combination meets primary goal in late-stage trial
GSK said on Monday (Dec 18) that a combination of its cancer drugs Zejula and Jemperli, when used as a maintenance therapy...
GSK sells £886 million stake in former consumer unit Haleon
GSK has raised £886 million (S$1.5 billion) from the latest sale of a tranche of shares in Haleon, the consumer-health business it...
GSK’s Tuas vaccine facility is Singapore’s largest after S$300 million investment: Gan Kim Yong
THE expansion of British drugmaker GSK’s facility at Tuas has earned it the title of Singapore’s largest vaccine production site based on...
GSK’s gonorrhea shot gets US FDA fast track as resistant cases multiply
GSK’s experimental gonorrhea vaccine got fast-track designation from US regulators, putting the shot in position to become the first preventive for a...
GSK sells US$1 billion discounted stake in spin-off Haleon
BRITISH drugmaker GSK on Friday (May 12) sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share...
US becomes first country to approve RSV vaccine
THE United States on Wednesday (May 3) approved the world’s first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a...
GSK to buy Bellus for US$2 billion to gain cough medicine
GSK agreed to buy Canadian biotech Bellus Health for about US$2 billion to bolster its pipeline of experimental medicines.
GSK posts strong results for cancer drug it sees as blockbuster
A GSK drug for endometrial cancer posted strong results in a trial, a sign it could become the top seller the British...